In Pink Sheet Pharma Intelligence, Katherine Wang Discusses China’s New Rules on Human Genetic Resources

In The News
June 8, 2023

On June 1, China’s Ministry of Science and Technology (the “MOST”) issued the long-awaited Implementing Rules on the Administrative Regulations on Human Genetic Resources (the “Implementing Rules”). A June 7 article by Pink Sheet Pharma Intelligence reviews the areas of tightened oversight, featuring insights from life sciences partner Katherine Wang (Shanghai).

“I think the implementation of the data privacy and cybersecurity regulations will likely pose more challenges to foreign life sciences companies’ operations in China,” Katherine stated in the piece.

Ropes & Gray’s client alert co-authored by Katherine Wang on the MOST’s Implementing Rules, outlining the six most noteworthy updates, can be reviewed here.